Chenghe Acquisition III
CHECU · NASDAQ
About CHECU
- Employees
- 0
- Listed
- Sep 16, 2025
- Sector
- N/A
- Industry
- N/A
- Website
- chengheinv.com
CHECU key statistics
- Market cap
- 178.10M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 10
- Volume
- 200
- Open price
- $10.42
- High today
- $10.42
- Low today
- $10.42
- 52 Week high
- $10.49
- 52 Week low
- $9.97
Chenghe Acquisition III (CHECU) at a glance
As of Nov 5, 2026, Chenghe Acquisition III (CHECU) shares are priced at $10.42, giving the company a market cap of 178.10M and a price-to-earnings ratio of 0.00.
Volume so far is 200 shares, above the average of 10 shares a day.
Over the past year Chenghe Acquisition III has ranged from $9.97 to $10.49, and now sits 87% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003+0.00%
- RCTRedCloud Holdings$0.0424+41.33%
- SHFSSHF Holdings$0.0263−1.13%
- SDASunCar Technology Group$0.3765+144.80%
- WDLFDecentral Life$0.0004+100.00%
- SEIISharing Economy International$0.0001−50.00%
- SOXLDirexion Shares ETF Trust$45.97+12.48%
- VIVKVivakor$0.4962+34.11%
- MASNMaison Luxe$0.0003−33.33%
- NBNDNetBrands$0.0005+11.11%
- NVDANVIDIA$186.64+2.78%
- INTCIntel$56.28+7.71%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.84−0.28%
- ASPEAspen Neuroscience$12.44+5.78%
- BBTXBambusa Therapeutics$15.73−0.76%
- GBCGEORGIA BANKING$33.10−1.93%
- BHAIUBHAV Acquisition Corp II$9.99+0.00%
- SCQCUSPACCircle Acquisition$10.00+0.10%
- LYCALycia Therapeutics$30.50+5.90%
- DAVIDAVION HEALTHCARE$1.59+21.37%
- TCXBTCGX Acquisition Corp. II$10.20−0.49%
- CTYCITY THERAPEUTICS$18.25+6.91%
- IAMIambic Therapeutics$10.17−12.63%
- AMROAmaero$5.45+1.87%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.